We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+15.41%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$292M
AUM Growth
+$33.2M
Cap. Flow
+$15.8M
Cap. Flow %
5.41%
Top 10 Hldgs %
30.62%
Holding
95
New
30
Increased
15
Reduced
22
Closed
25

Top Buys

Rank Stock Value
1
HUBS icon
HubSpot
HUBS
+$7.19M
2
ETSY icon
Etsy
ETSY
+$5.96M
3
MSFT icon
Microsoft
MSFT
+$5.4M
4
PODD icon
Insulet
PODD
+$5.28M
5
XYZ
Block Inc
XYZ
+$3.86M

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$4.76M
2
AAL icon
American Airlines Group
AAL
+$4.11M
3
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$4.09M
4
AERI
Aerie Pharmaceuticals
AERI
+$3.92M
5
ELV icon
Elevance Health
ELV
+$3.71M

Sector Composition

Rank Sector Weight
1 Healthcare 33.07%
2 Technology 24.95%
3 Communication Services 12.72%
4 Consumer Discretionary 6.59%
5 Materials 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNY icon
26
Alnylam Pharmaceuticals
ALNY
$29.3B
$4.88M 1.67%
41,000
+16,000
+64% +$2.06M
RHT
27
DELISTED
Red Hat Inc
RHT
$4.63M 1.59%
31,000
+7,000
+29% +$970K
FND icon
28
Floor & Decor
FND
$6.46B
$4.57M 1.56%
87,600
-5,400
-6% -$255K
ICUI icon
29
ICU Medical
ICUI
$4.3B
$4.54M 1.56%
18,000
-1,000
-5% -$235K
ASIX icon
30
AdvanSix
ASIX
$546M
$4.39M 1.5%
126,291
+21,291
+20% +$839K
XYZ
31
Block Inc
XYZ
$50.4B
$4.13M 1.42%
+84,000
New +$3.86M
BLUE
32
DELISTED
bluebird bio
BLUE
$4.1M 1.4%
1,853
-193
-9% -$491K
INGN icon
33
Inogen
INGN
$187M
$3.93M 1.35%
32,000
+11,000
+52% +$1.34M
PTLA
34
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$3.69M 1.26%
+113,000
New +$4.96M
SAGE
35
DELISTED
Sage Therapeutics
SAGE
$3.46M 1.19%
21,500
+15,500
+258% +$2.63M
NOW icon
36
ServiceNow
NOW
$122B
$3.31M 1.13%
+100,000
New +$3.09M
PEN icon
37
Penumbra
PEN
$12.8B
$3.3M 1.13%
+28,500
New +$2.94M
OKTA icon
38
Okta
OKTA
$25.7B
$3.27M 1.12%
+82,000
New +$2.74M
AIMT
39
DELISTED
Aimmune Therapeutics
AIMT
$3.12M 1.07%
98,000
+13,000
+15% +$457K
ARGX icon
40
argenx
ARGX
$52.8B
$2.98M 1.02%
+37,000
New +$2.79M
AZUL
41
DELISTED
Azul
AZUL
$2.95M 1.01%
+85,000
New +$2.5M
ESPR
42
DELISTED
Esperion Therapeutics
ESPR
$2.89M 0.99%
40,000
-16,000
-29% -$1.17M
QTWO icon
43
Q2 Holdings
QTWO
$3.99B
$2.87M 0.98%
+63,000
New +$2.72M
EPAM icon
44
EPAM Systems
EPAM
$5.85B
$2.86M 0.98%
+25,000
New +$2.86M
LOXO
45
DELISTED
Loxo Oncology, Inc
LOXO
$2.48M 0.85%
+21,500
New +$2.29M
VRTX icon
46
Vertex Pharmaceuticals
VRTX
$121B
$2.44M 0.84%
15,000
+3,000
+25% +$490K
DXCM icon
47
DexCom
DXCM
$32.8B
$2.37M 0.81%
+128,000
New +$1.89M
ABBV icon
48
AbbVie
ABBV
$431B
$2.37M 0.81%
+25,000
New +$2.75M
NTNX icon
49
Nutanix
NTNX
$16.6B
$2.36M 0.81%
+48,000
New +$1.9M
JPM icon
50
JPMorgan Chase
JPM
$950B
$2.23M 0.76%
20,300
+300
+2% +$34K
1
2
3 4

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return
Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Atika Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Atika Capital Management held 95 positions worth $292M, up 13% from $259M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Atika Capital Management deployed $15.8M of net new capital in Q1 2018, opening 30 new positions and adding to 15 existing holdings. Its largest new stake was HubSpot: 69,000 shares worth $7.47M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Goldman Sachs, an estimated $3.25M trimmed.

  • Atika Capital Management's largest Q1 2018 buy was HubSpot: 69,000 shares worth $7.47M.
  • Atika Capital Management added most to Microsoft in Q1 2018, an estimated $5.4M increase.
  • Atika Capital Management's biggest Q1 2018 reduction was Goldman Sachs, cutting an estimated $3.25M.
  • Atika Capital Management fully exited CATALENT, INC. in Q1 2018, selling an estimated $4.76M.
  • Atika Capital Management's ten largest holdings make up 31% of its $292M portfolio in Q1 2018.
  • Atika Capital Management opened 30 new positions and closed 25 in Q1 2018.
  • Atika Capital Management's portfolio value rose 13% quarter-over-quarter to $292M.

Based on Atika Capital Management's 13F filing for Q1 2018, filed 15 May 2018.